Emerging in the landscape of obesity treatment, retatrutide is a unique strategy. Beyond many available medications, retatrutide functions as a dual agonist, simultaneously engaging both glucagon-like peptide-1 (GLP-1) https://elainebmim122110.blogoscience.com/45219105/the-novel-retatrutide-the-glp-gip-sensor-agonist